HR vi­o­la­tion push­es Re­vance co-founder out, vault­ing for­mer Zel­tiq chief to the helm

Months af­ter Re­vance amend­ed the terms of its Botox biosim­i­lar col­lab­o­ra­tion with My­lan, the Newark, Cal­i­for­nia-based drug de­vel­op­er dis­closed its co-founder Dan Browne is step­ping …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER